8 Feb 2022 , 01:59 PM
Net profit of Suven Pharmaceuticals rose 40.87% to Rs 160.07 crore in the quarter ended December 2021 as against Rs 113.63 crore during the previous quarter ended December 2020. Sales rose 42.43% to Rs 391.59 crore in the quarter ended December 2021 as against Rs 274.93 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 391.59 | 274.93 | 42 |
| OPM % | 47.50 | 49.95 | – |
| PBDT | 249.96 | 156.26 | 60 |
| PBT | 239.46 | 147.50 | 62 |
| NP | 160.07 | 113.63 | 41 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
